…REPORT FROM THE AAN, APRIL 10-17, 2010 – In 2008, Italian researchers reported that lithium 300-450 mg/day delayed disease progression in amyotrophic lateral sclerosis (Fornai et al. PNAS 2008; 105: 2052-2057; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC2538879/?tool=pubmed). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…ts following intracerebral hemorrhage (ICH) (Garrett et al. Neurocrit Care 2010; 12: 199-203; Hays & Diringer. Neurology 2006; 66: 1330-1334; Chung et al. J Korean Neurosurg Soc 2009; 45: 355-359. Free full text at www.jkns.or.kr/htm/fulltext.asp?no=0042009075). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
REPORT FROM THE AAN, APRIL 10-17, 2010 – Over 4,000 MS patients signed on to the National MS Society press conference and webinar on chronic cerebrospinal venous insufficiency (CCSVI), held April 14th, 2010, during the AAN annual meeting (See Special Report: CCSVI, NeuroSens, February 17, 2010). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Conti…
…A double-blind, placebo-controlled study in Austria reports that nutritional supplementation with omega-3 polyunsaturated fatty acid (PUFA) reduces progression to first-episode psychotic disorder in high-risk individuals (Amminger et al. Arch Gen Psychiatry 2010; 67: 146-154). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…Low-dose topiramate appears to be as effective as the atypical antipsychotic agent risperidone in controlling behavioural disturbances in AD patients, according to the results of a double-blind trial (Mowla & Pani. J Clin Psychopharmacol 2010; 30: 40-43). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…